Rilly La Montagne, France

Dominique Boucherot


Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1991-1994

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dominique Boucherot

Introduction

Dominique Boucherot is a notable inventor based in Rilly La Montagne, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin compounds. With a total of 3 patents to his name, Boucherot's work has had a considerable impact on medicinal chemistry.

Latest Patents

Boucherot's latest patents include innovative formulations of cephalosporin derivatives. These derivatives feature a 3-position substituent, which is crucial for enhancing the efficacy of the compounds. The patents describe bicyclo-heterocyclic intermediates that are bonded via a carbon atom to the amide linkage. The heterocyclic rings are selected from a variety of structures, including pyrazinone, pyridinone, and pyrimidinone rings, among others. This innovative approach aims to improve the therapeutic properties of cephalosporins, making them more effective in treating bacterial infections.

Career Highlights

Throughout his career, Boucherot has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Imperial Chemical Industries Limited and ICI Pharma. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Boucherot has collaborated with several esteemed professionals in his field, including Frederick H. Jung and Colin J. Strawson. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Dominique Boucherot's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his importance as an inventor. His work continues to influence the development of effective medicinal compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…